Undervalued over 20% based on DCF

Results

4880

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

4880 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MSFT
US$373.94-5.1%-23.7%US$2.7tUS$561.3922.213.4%1.0%Software
AMZN
US$234.11-4.8%10.0%US$2.5tUS$312.9927.716.4%n/aRetail
SPCX
US$156.11-22.6%n/aUS$2.0tUS$187.80106.665.4%n/aTelecom
A000660
₩2,550,000.007.1%815.6%₩2067.5t₩2,784,594.3424.041.5%0.1%Semiconductors
BRK.A
US$737,800.05-0.6%-0.3%US$1.1tUS$758,899.0014.6-2.4%n/aDiversified Financials
LLY
US$1,107.08-1.4%42.3%US$982.8bUS$1,218.7239.116.7%0.6%Pharmaceuticals & Biotech
JPM
US$334.140.9%18.8%US$888.2bUS$342.002.63.9%1.8%Banks
XOM
US$139.73-1.5%29.0%US$573.9bUS$170.2422.910.1%2.9%Energy
JNJ
US$239.081.7%57.1%US$556.8bUS$257.3227.48.3%2.2%Pharmaceuticals & Biotech
ABBV
US$234.765.5%26.5%US$406.4bUS$253.83115.425.1%2.9%Pharmaceuticals & Biotech
HSBA
UK£14.462.6%63.1%UK£248.9bUK£14.491.711.3%3.9%Banks
NFLX
US$72.82-7.5%-43.1%US$306.9bUS$114.1522.912.0%n/aMedia
MRK
US$119.603.8%48.9%US$285.2bUS$130.1133.121.2%2.8%Pharmaceuticals & Biotech
300750
CN¥392.51-2.7%59.6%CN¥1.9tCN¥558.0622.816.4%2.0%Capital Goods
AZN
UK£135.902.3%31.5%UK£206.1bUK£166.9026.813.5%1.7%Pharmaceuticals & Biotech
WFC
US$84.13-1.1%7.7%US$256.6bUS$96.111.64.5%2.1%Banks
WDC
US$670.75-1.5%980.6%US$252.5bUS$554.1336.417.8%0.09%Tech
NESN
CHF 80.220.8%-2.1%CHF 203.2bCHF 87.8722.88.2%3.9%Food, Beverage & Tobacco
C
US$144.971.4%78.7%US$248.5bUS$147.071.39.8%1.7%Banks
BABA
US$102.60-7.5%-12.3%US$239.7bUS$190.1115.015.4%1.0%Retail
IBM
US$264.94-2.2%-9.8%US$237.1bUS$293.8923.25.8%2.6%Software
8306
JP¥3,267.001.2%65.7%JP¥37.6tJP¥3,231.671.75.8%2.9%Banks
ECO
US$10.210%172.2%US$26.4bn/an/an/a0.03%Telecom
SAN
€11.932.5%68.7%€172.1b€12.211.614.5%2.1%Banks
Page 1 of 136